136 related articles for article (PubMed ID: 1484530)
1. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.
Blin J; Vidailhet MJ; Pillon B; Dubois B; Feve JR; Agid Y
Mov Disord; 1992 Oct; 7(4):348-54. PubMed ID: 1484530
[TBL] [Abstract][Full Text] [Related]
2. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
[TBL] [Abstract][Full Text] [Related]
3. Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
Hirato M; Horikoshi S; Kawashima Y; Satake K; Shibazaki T; Ohye C
Adv Neurol; 1993; 60():511-4. PubMed ID: 8420180
[No Abstract] [Full Text] [Related]
4. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
Nagasawa H; Tanji H; Nomura H; Saito H; Itoyama Y; Kimura I; Tuji S; Fujiwara T; Iwata R; Itoh M; Ido T
J Neurol Sci; 1996 Aug; 139(2):210-7. PubMed ID: 8856655
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
Klaffke S; Kuhn AA; Plotkin M; Amthauer H; Harnack D; Felix R; Kupsch A
Mov Disord; 2006 Oct; 21(10):1724-7. PubMed ID: 16773621
[TBL] [Abstract][Full Text] [Related]
6. Reduced regional cerebral metabolic rate for glucose at the terminal stage in a case of late infantile neuronal ceroid lipofuscinosis.
Fueki N; Iinuma K; Kojima A; Yanai K; Haginoya K; Tada K; Ido T; Ito M
J Child Neurol; 1990 Apr; 5(2):98-100. PubMed ID: 2345285
[TBL] [Abstract][Full Text] [Related]
7. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.
Eidelberg D; Takikawa S; Moeller JR; Dhawan V; Redington K; Chaly T; Robeson W; Dahl JR; Margouleff D; Fazzini E
Ann Neurol; 1993 May; 33(5):518-27. PubMed ID: 8498828
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomographic studies during serial word-reading by normal and dyslexic adults.
Gross-Glenn K; Duara R; Barker WW; Loewenstein D; Chang JY; Yoshii F; Apicella AM; Pascal S; Boothe T; Sevush S
J Clin Exp Neuropsychol; 1991 Jul; 13(4):531-44. PubMed ID: 1918284
[TBL] [Abstract][Full Text] [Related]
9. Contribution of PET studies in diagnosis of corticobasal degeneration.
Lutte I; Laterre C; Bodart JM; De Volder A
Eur Neurol; 2000; 44(1):12-21. PubMed ID: 10894990
[TBL] [Abstract][Full Text] [Related]
10. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism.
Siegel BV; Asarnow R; Tanguay P; Call JD; Abel L; Ho A; Lott I; Buchsbaum MS
J Neuropsychiatry Clin Neurosci; 1992; 4(4):406-14. PubMed ID: 1422167
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET.
Shinotoh H; Hirayama K; Tateno Y
Adv Neurol; 1993; 60():488-93. PubMed ID: 8420176
[No Abstract] [Full Text] [Related]
12. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration.
De Volder AG; Francart J; Laterre C; Dooms G; Bol A; Michel C; Goffinet AM
Ann Neurol; 1989 Aug; 26(2):239-47. PubMed ID: 2789014
[TBL] [Abstract][Full Text] [Related]
13. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
Martin PR; Rio D; Adinoff B; Johnson JL; Bisserbe JC; Rawlings RR; Rohrbaugh JW; Stapleton JM; Eckardt MJ
J Neuropsychiatry Clin Neurosci; 1992; 4(2):159-67. PubMed ID: 1627977
[TBL] [Abstract][Full Text] [Related]
14. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
[TBL] [Abstract][Full Text] [Related]
15. Altered frontostriatal relationship in unmedicated schizophrenic patients.
Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
[TBL] [Abstract][Full Text] [Related]
16. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S
Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143
[TBL] [Abstract][Full Text] [Related]
17. The value of positron emission tomography in the diagnosis and monitoring of late infantile and juvenile lipopigment storage disorders (so-called Batten or neuronal ceroid lipofuscinoses).
Philippart M; da Silva E; Chugani HT
Neuropediatrics; 1997 Feb; 28(1):74-6. PubMed ID: 9151330
[TBL] [Abstract][Full Text] [Related]
18. [Three-dimensional surface display with 123I-IMP in corticobasal degeneration].
Okuda B; Kawabata K; Takeda M; Tachibana H; Sugita M
Rinsho Shinkeigaku; 1992 Jul; 32(7):774-6. PubMed ID: 1291176
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
Przedborski S; Goldman S; Giladi N; Dhawan V; Takikawa S; Hildebrand J; Fahn S; Eidelberg D
Adv Neurol; 1993; 60():501-5. PubMed ID: 8420178
[No Abstract] [Full Text] [Related]
20. The effect of anxiety and hostility in silent mentation on localized cerebral glucose metabolism.
Gottschalk LA; Buchsbaum MS; Gillin JC; Wu J; Reynolds CA; Herrera DB
Compr Psychiatry; 1992; 33(1):52-9. PubMed ID: 1555410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
